Loading clinical trials...
Loading clinical trials...
Effect of Sugammadex Versus Neostigmine on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: a Randomized Controlled Trial
Perioperative respiratory adverse events are common in children. We aimed to evaluate the effect of sugammadex on the incidence of perioperative respiratory adverse events in pediatric patients receiving tonsillectomy
Age
2 - 6 years
Sex
ALL
Healthy Volunteers
No
Seoul national university hospital
Seoul, South Korea
Start Date
June 27, 2022
Primary Completion Date
September 4, 2024
Completion Date
September 4, 2024
Last Updated
September 20, 2024
174
ACTUAL participants
Sugammadex injection
DRUG
Neostigmine
DRUG
Lead Sponsor
Seoul National University Hospital
NCT06719258
NCT06412081
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06443515